IL-6/gp130 signaling: a key unlocking regeneration

被引:0
|
作者
Ruopu Li
Deqiang Li
Yu Nie
机构
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Cardiovascular Disease, Fuwai Hospital & Cardiovascular Institute, National Center for Cardiovascular Disease
[2] the Research Institute at Nationwide Children’s Hospital,The Center for Cardiovascular Research
[3] Ohio State University,The Department of Pediatrics, College of Medicine
[4] Fuwai Central-China Hospital,National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine
[5] Central China Branch of National Center for Cardiovascular Diseases,Shenzhen Key Laboratory of Cardiovascular Disease
[6] Fuwai Hospital Chinese Academy of Medical Sciences,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Liver is an organ with notable capacity of regeneration. Reprogramming of hepatocytes towards an immature state is one of the important mechanisms for hepatocyte replenishment. Inflammatory response mediated by IL-6 and its family cytokines has been widely reported closely related with tissue regeneration in myriads of organs. Recently Hui and colleagues reported that the dedifferentiation of hepatocytes depends upon IL-6 signaling from Kupffer cells and the reprogramming of gene expression under the inflammatory condition is different from the regulation of gene expression during embryo hepatocyte specification, highlighting a tight linkage between extracellular microenvironment and parenchymal cell plasticity during tissue regenerative repair.
引用
收藏
相关论文
共 50 条
  • [11] Activation of gp130 by IL-6 soluble IL-6 receptor induces neuronal differentiation
    März, P
    Herget, T
    Lang, E
    Otten, U
    Rose-John, S
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1997, 9 (12) : 2765 - 2773
  • [12] 2 DISTINCT AND INDEPENDENT SITES ON IL-6 TRIGGER GP130 DIMER FORMATION AND SIGNALING
    PAONESSA, G
    GRAZIANI, R
    DESERIO, A
    SAVINO, R
    CIAPPONI, L
    LAHM, A
    SALVATI, AL
    TONIATTI, C
    CILIBERTO, G
    EMBO JOURNAL, 1995, 14 (09): : 1942 - 1951
  • [13] Specific inhibition of IL-6 signaling with monoclonal antibodies directed against the gp130 receptor
    Liautard, J
    Sun, RX
    Cotte, N
    Gaillard, JP
    Mani, JC
    Klein, B
    Brochier, J
    TISSUE ANTIGENS, 1996, 48 (4-II): : CR205 - CR205
  • [14] Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy
    Xiao, Hui
    Bid, Hemant Kumar
    Chen, Xiang
    Wu, Xiaojuan
    Wei, Jia
    Bian, Yang
    Zhao, Chengguang
    Li, Huameng
    Li, Chenglong
    Lin, Jiayuh
    PLOS ONE, 2017, 12 (07):
  • [15] Dysregulated IL-6/GP130/JAK Signaling in Calreticulin Mutated Myeloproliferative Neoplasms (MPN)
    Balliu, Manjola
    Calabresi, Laura
    Bartalucci, Niccolo
    Maggi, Laura
    Annunziato, Francesco
    Guglielmelli, Paola
    Vannucchi, Alessandro M.
    BLOOD, 2019, 134
  • [16] Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase
    Giordano, V
    DeFalco, G
    Chiari, R
    Quinto, I
    Pelicci, PG
    Bartholomew, L
    Delmastro, P
    Gadina, M
    Scala, G
    JOURNAL OF IMMUNOLOGY, 1997, 158 (09): : 4097 - 4103
  • [17] Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses
    Müller-Newen, G
    Küster, A
    Hemmann, U
    Keul, R
    Horsten, U
    Martens, A
    Graeve, L
    Wijdenes, J
    Heinrich, PC
    JOURNAL OF IMMUNOLOGY, 1998, 161 (11): : 6347 - 6355
  • [18] Small molecules targeting IL-6/GP130 homodimerization in the IL-6/JAK/STAT pathway
    Jena, Nivedita
    Kumari, Vandana
    Mok, May
    Lin, Li
    Li, Pui-Kai
    Lin, Jiayuh
    Li, Chenglong
    Fuchs, James R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [19] IL-6 and gp130 signalling: its role in chronic disease
    Senior, K
    MOLECULAR MEDICINE TODAY, 1999, 5 (07): : 283 - 283
  • [20] Targeted disruption of the IL-6 related genes: gp130 and NF-IL-6
    Akira, S
    Yoshida, K
    Tanaka, T
    Taga, T
    Kishimoto, T
    IMMUNOLOGICAL REVIEWS, 1995, 148 : 221 - 253